welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
Cardiac Magnetic Resonance in Children With Muscular Dystrophy
study id #: NCT01081080
condition: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy
This protocol will exploit novel state of the art cardiovascular magnetic resonance techniques to examine important changes in the heart in children with muscular dystrophy. The purpose of this study is to compare cardiac magnetic resonance (CMR) with the collected cardiac outcome data obtained in protocol: PITT1109 – Cardiac Outcome Measures in Children with Muscular Dystrophy.
mechanism of action: No pharmaceutical intervention
last updated: November 22, 2018
start date: April 2010
estimated completion: October 2011
size / enrollment: 20
Participant enrolled in the CINRG study: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy
• Pregnant woman (when uncertain, participants will undergo urine testing) or lactating women
• Decompensated congestive heart failure (unable to lie flat during CMR)
• Impaired renal excretory function (calculated Glomerular Filtration Rate less than 30mL/min)
• Contra-indications to Magnetic Resonance Imaging:
-Cardiac pacemaker or implantable defibrillator
-Cerebral aneurysm clip
-Metallic ocular foreign body
-Any implanted device (i.e. insulin pump, drug infusion device)
-Metal shrapnel or bullet
PoC Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With DMDA Phase 2 Clinical Study to Assess the A...
Electrical Impedance Myography in Duchenne Muscular Dystrophy: A Longitudinal StudyObjective:To evaluate the capability of ...
Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)The purpose of this study is to see whet...
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular DystrophyTo characterize the natural history and ...
The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (...Background: We want to learn more about ...
Clinical trial of gene therapy for Duchenne muscular dystrophy underway at University of Florida HealthScreening has resumed in a clinical tria...
Catabasis Pharmaceuticals Presents Data Supporting MRI T2 as a Potential Marker of Clinical Outcome in Duchenne Musc...Catabasis Pharmaceuticals, Inc. (NASDAQ:...
Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large Duchenne muscular dystrophy c...Objective: The aim of this study was to...
Katy Eichinger, PhD, DPTKaty Eichinger is an assistant professor...